Erste Group Bank upgraded shares of Intuitive Surgical (NASDAQ:ISRG – Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning,Benzinga reports.
ISRG has been the topic of a number of other research reports. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. BTIG Research set a $535.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Leerink Partners increased their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Piper Sandler restated an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $524.61.
Get Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Stock Performance
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, analysts forecast that Intuitive Surgical will post 5.45 EPS for the current year.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 396 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,680,761.28. The trade was a 6.71 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the transaction, the general counsel now owns 1,595 shares in the company, valued at $757,625. This trade represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,935 shares of company stock valued at $26,305,169. Corporate insiders own 0.90% of the company’s stock.
Institutional Investors Weigh In On Intuitive Surgical
Several institutional investors have recently added to or reduced their stakes in the stock. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Intuitive Surgical by 10,606.9% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 12,420 shares of the medical equipment provider’s stock worth $4,957,000 after buying an additional 12,304 shares during the period. Crewe Advisors LLC bought a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $161,000. CreativeOne Wealth LLC raised its holdings in shares of Intuitive Surgical by 41.2% in the first quarter. CreativeOne Wealth LLC now owns 2,324 shares of the medical equipment provider’s stock valued at $927,000 after purchasing an additional 678 shares during the last quarter. Freestone Capital Holdings LLC lifted its position in shares of Intuitive Surgical by 2.9% in the first quarter. Freestone Capital Holdings LLC now owns 7,471 shares of the medical equipment provider’s stock worth $2,982,000 after purchasing an additional 208 shares in the last quarter. Finally, Axxcess Wealth Management LLC boosted its holdings in Intuitive Surgical by 18.1% during the first quarter. Axxcess Wealth Management LLC now owns 10,551 shares of the medical equipment provider’s stock worth $4,211,000 after purchasing an additional 1,618 shares during the last quarter. 83.64% of the stock is owned by institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- What Makes a Stock a Good Dividend Stock?
- Tesla Investors Continue to Profit From the Trump Trade
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What is a support level?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.